Yongkang Zou

2PUBLICATIONS
14CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 02, 2025
UFMylation: A supervisor of the HIF1α pathway and a potential therapeutic target for anti-PD-1 combination therapy in hypoxic tumors.

Yongkang Zou, Zhaoxiang Wang, Qiang Jiang

|Mar 09, 2023
Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target.

Junzhi Zhou, Xiaohe Ma, Xingrui He

Pageof 1